Brief: Neovacs FY operating loss widens to 17.3 million euros
March 30 (Reuters) - Neovacs SA ALNEV.PA :
* FY revenue 0.4 million euros versus 1.2 million euros ($1.29 million) year ago
* FY operating loss of 17.3 million euros versus loss of 11.3 million euros year ago
* FY net loss of 13.9 million euros versus loss of 4.7 million euros year ago
Source text for Eikon: ID:nGNEj1b76
Further company coverage: ALNEV.PA
($1 = 0.9325 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants